Cargando…
Corrigendum: Prostaglandin reductase 1 as a potential therapeutic target for cancer therapy
Autores principales: | Wang, Xing, Yin, Guobing, Zhang, Wei, Song, Kunling, Zhang, Longbin, Guo, Zufeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10250026/ https://www.ncbi.nlm.nih.gov/pubmed/37305537 http://dx.doi.org/10.3389/fphar.2023.1220144 |
Ejemplares similares
-
Prostaglandin Reductase 1 as a Potential Therapeutic Target for Cancer Therapy
por: Wang, Xing, et al.
Publicado: (2021) -
Biliverdin reductase: a target for cancer therapy?
por: Gibbs, Peter E. M., et al.
Publicado: (2015) -
Corrigendum: Targeted therapy in cardiovascular disease: A precision therapy era
por: Xu, Mengda, et al.
Publicado: (2023) -
The Prostaglandin F Synthase Activity of the Human Aldose Reductase AKR1B1 Brings New Lenses to Look at Pathologic Conditions
por: Bresson, Eva, et al.
Publicado: (2012) -
Corrigendum: Therapeutic potential of topical administration of acriflavine against hypoxia-inducible factors for corneal fibrosis
por: Zhu, Shuyan, et al.
Publicado: (2023)